KOHJIN BIO CO LTD (177A.T)

JPY 1703.0

(-0.12%)

Gross Profit Summary of KOHJIN BIO CO LTD

  • KOHJIN BIO CO LTD's latest annual gross profit in 2023 was 1.88 Billion JPY , down -23.34% from previous year.
  • KOHJIN BIO CO LTD's latest quarterly gross profit in 2023 FY was 1.88 Billion JPY , down -23.34% from previous quarter.
  • KOHJIN BIO CO LTD reported a annual gross profit of 2.45 Billion JPY in annual gross profit 2022, up 20.35% from previous year.
  • KOHJIN BIO CO LTD reported a annual gross profit of 2.03 Billion JPY in annual gross profit 2021, down 0.0% from previous year.
  • KOHJIN BIO CO LTD reported a quarterly gross profit of 571.25 Million JPY for 2023 Q4, down 0.0% from previous quarter.
  • KOHJIN BIO CO LTD reported a quarterly gross profit of 2.45 Billion JPY for 2022 FY, up 20.35% from previous quarter.

Annual Gross Profit Chart of KOHJIN BIO CO LTD (2023 - 2021)

Historical Annual Gross Profit of KOHJIN BIO CO LTD (2023 - 2021)

Year Gross Profit Gross Profit Growth
2023 1.88 Billion JPY -23.34%
2022 2.45 Billion JPY 20.35%
2021 2.03 Billion JPY 0.0%

Peer Gross Profit Comparison of KOHJIN BIO CO LTD

Name Gross Profit Gross Profit Difference
PRISM BioLab Co.,LTD 80.3 Million JPY -2242.659%
GNI Group Ltd. 22.43 Billion JPY 91.613%
Linical Co., Ltd. 3.77 Billion JPY 50.208%
Trans Genic Inc. 2.24 Billion JPY 16.359%
MEDINET Co., Ltd. 98.25 Million JPY -1814.766%
Soiken Holdings Inc. 2.48 Billion JPY 24.214%
Cytori Cell Research Institute, Inc. 1.29 Billion JPY -45.542%
AnGes, Inc. -3.06 Billion JPY 161.374%
OncoTherapy Science, Inc. -177.71 Million JPY 1158.585%
Nxera Pharma Co., Ltd. 9.66 Billion JPY 80.533%
Immuno-Biological Laboratories Co., Ltd. 517.29 Million JPY -263.681%
NanoCarrier Co., Ltd. 110.95 Million JPY -1595.533%
Carna Biosciences, Inc. 1.45 Billion JPY -29.691%
CanBas Co., Ltd. -984 Million JPY 291.189%
D. Western Therapeutics Institute, Inc. 391.69 Million JPY -380.292%
RaQualia Pharma Inc. 1.65 Billion JPY -13.595%
Chiome Bioscience Inc. 398.59 Million JPY -371.982%
Kidswell Bio Corporation 1.03 Billion JPY -81.001%
PeptiDream Inc. 17.21 Billion JPY 89.074%
Oncolys BioPharma Inc. 30.6 Million JPY -6047.022%
Ribomic Inc. -10.5 Million JPY 18013.693%
SanBio Company Limited -14.5 Million JPY 13070.877%
Healios K.K. 108 Million JPY -1641.941%
BrightPath Biotherapeutics Co., Ltd. -341 Thousand JPY 551799.707%
Kubota Pharmaceutical Holdings Co., Ltd. -59.04 Million JPY 3286.153%
Delta-Fly Pharma, Inc. -1.51 Million JPY 124524.339%
StemRIM -44.34 Million JPY 4342.026%
CellSource Co., Ltd. 3.18 Billion JPY 40.933%
FunPep Company Limited -680.28 Million JPY 376.544%
Kringle Pharma, Inc. 69.25 Million JPY -2616.673%
Stella Pharma Corporation 217.29 Million JPY -765.768%
TMS Co., Ltd. -6.95 Million JPY 27169.007%
Noile-Immune Biotech Inc. 314.56 Million JPY -498.07%
Cuorips Inc. 9.63 Million JPY -19433.756%
K Pharma,Inc. 910 Million JPY -106.736%
Takara Bio Inc. 25.45 Billion JPY 92.61%
ReproCELL Incorporated 1.1 Billion JPY -70.296%
PhoenixBio Co., Ltd. 1.19 Billion JPY -57.423%
StemCell Institute Inc. 1.57 Billion JPY -19.381%
Japan Tissue Engineering Co., Ltd. 1.66 Billion JPY -12.87%
CellSeed Inc. 107.15 Million JPY -1655.677%